MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Progression of sleep disorders spectrum in Parkinson’s Disease: A 5 year clinical longitudinal study

Meeting: 2018 International Congress

Abstract Number: 1641

Keywords: Excessive daytime sleepiness(EDS), Rapid eye movement(REM)

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To investigate longitudinal changes in the prevalence of different sleep disorders in the PPMI cohort of patients with Parkinson’s Disease (PD).

Background: Sleep disturbances are common in advanced PD but they are frequently present also in the early and prodromal stages of disease. However, little is known about the prevalence and potential interactions between different types of sleep disorders and their evolution over time, particularly in the natural history of early PD.

Methods: Data was obtained from the Parkinson Progression Markers Initiative (PPMI) database. REM sleep behavior Disorder (RBD), excessive daytime sleepiness (EDS), and insomnia were defined using the RBD Screening Questionnaire (>5), Epworth Sleepiness Score (> or = 10) and UPDRS Part 1.7 (> or = 2).

Results: Two hundred and eighteen PD patients with a completed 5 year-clinical follow-up were included. At baseline, 55.5% PD patients did not report any sleep complaint. 31.7% of PD patients reported 1 sleep disorder: 12.8% reported insomnia only, 10.6% reported RBD only, and 8.3% EDS only. 11.5% PD patients reported 2 sleep disorders: 5.0% reported EDS and RBD, 4.1% reported both insomnia and RBD, and 2.3%reported both insomnia and EDS. Only 1.4% PD patients reported all 3 sleep disorders. At 5 years, the percentage of patients with no sleep complaints was reduced to 30.3%. 39.0% PD patients reported 1 sleep complaint: 19.3% reported insomnia only, 11.0% reported RBD only, and 8.7% reported EDS only. 23.4% of PD patients reported 2 sleep disorders: 10.6% reported insomnia and EDS, 7.3% reported insomnia and RBD, and 5.5% reported RBD and EDS. 7.3% PD patients reported 3 sleep disorders. The largest increase in reported prevalence was seen for insomnia, followed by EDS and then RBD. At baseline, 20.6% of PD subjects reported insomnia which increased to 55.5% at 5 years (p<0.001); 17.0% of PD subjects reported EDS which increased to 32.1% at 5 years (p<0.001); 21.1% of PD subjects reported RBD, which increased to 31.2% at 5 years (p=0.005).

Conclusions: Although sleep disorders are common in early PD, one-third of PD patients in the PPMI cohort remained free of sleep complaints 5 years after disease onset. Amongst the sleep disorders studied, the greatest reported increase in prevalence over the 5-year period was observed for insomnia, followed by EDS and RBD. The number of patients with multiple sleep disorders was relatively low suggesting that they can have different pathogenesis.

To cite this abstract in AMA style:

. Progression of sleep disorders spectrum in Parkinson’s Disease: A 5 year clinical longitudinal study [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/progression-of-sleep-disorders-spectrum-in-parkinsons-disease-a-5-year-clinical-longitudinal-study/. Accessed May 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/progression-of-sleep-disorders-spectrum-in-parkinsons-disease-a-5-year-clinical-longitudinal-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley